Huntington disease in Canada
Key links
Snapshot: Huntington disease: A focus on long-term care, medication use and clinic visits
Data tables: Huntington Disease in Canada — Data Tables (XLSX)
Methodology notes: Huntington Disease in Canada — Methodology Notes (PDF)
November 21, 2024 — Huntington disease (HD) is a rare inherited neurodegenerative disorder with physical, cognitive and psychiatric symptoms. This release examines adult HD in long-term care (LTC) and clinic settings, including drugs prescribed to LTC residents with HD. Learn about the demographics and health characteristics of LTC residents with HD, the top drugs prescribed to LTC residents with this disease and clinic visits for patients with HD. Findings are summarized with input from patient partners.
Key findings
- LTC residents with Huntington disease require a wide range of care services.
- Medications play a large role in symptom management of LTC residents with Huntington disease.
- Despite advancements in diagnostic tools, Huntington disease may be misunderstood by health care professionals.
Featured material
Huntington disease: A focus on long-term care, medication use and clinic visits
Learn about patients with HD and their care in selected health care settings.
Read snapshot
Methodology notes
Definitions, data sources and methodologies used in the analyses.
Key links
Snapshot: Huntington disease: A focus on long-term care, medication use and clinic visits
Data tables: Huntington Disease in Canada — Data Tables (XLSX)
Methodology notes: Huntington Disease in Canada — Methodology Notes (PDF)
How to cite:
Canadian Institute for ºìÁì½í¹Ï±¨ Information. Huntington disease in Canada. Accessed April 6, 2025.
If you would like ºìÁì½í¹Ï±¨information in a different format, visit our Accessibility page.